Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer

Molecular profiling of circulating cell-free DNA (cfDNA) has shown utility for the management of colorectal cancer (CRC). TruSight Tumor 170 (TST170) is a next-generation sequencing (NGS) panel that covers 170 cancer-related genes, including KRAS, which is a key driver gene in CRC. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Casanova, Aitor, Bao-Caamano, Aida, Lago-Lestón, Ramón M., Brozos-Vázquez, Elena, Costa-Fraga, Nicolás, Ferreirós-Vidal, Isabel, Abdulkader, Ihab, Vidal-Insua, Yolanda, Rivera, Francisca Vázquez, Candamio Folgar, Sonia, López-López, Rafael, Muinelo-Romay, Laura, Diaz-Lagares, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509146/
https://www.ncbi.nlm.nih.gov/pubmed/34640513
http://dx.doi.org/10.3390/jcm10194487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509146/
https://www.ncbi.nlm.nih.gov/pubmed/34640513
http://dx.doi.org/10.3390/jcm10194487

Ejemplares similares